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Abstract Aim: Lower socioeconomic status (SES) is associated with a higher risk of
late-stage cancer diagnosis. A number of explanations have been advanced for this, but one
which has attracted recent attention is lower patient knowledge of cancer warning signs, lead-
ing to delay in help-seeking. However, although there is psychometric evidence of SES differ-
ences in knowledge of cancer symptoms, no studies have examined differences in ‘cancer
suspicion’ among people who are actually experiencing a classic warning sign.
Methods: A ‘health survey’ was mailed to 9771 adults (P50 years, no cancer diagnosis) with a
symptom list including 10 cancer ‘warning signs’. Respondents were asked if they had experi-
enced any of the symptoms in the past 3 months, and if so, were asked ‘what do you think caused
it?’ Any mention of cancer was scored as ‘cancer suspicion’. SES was indexed by education.
Results: Nearly half the respondents (1732/3756) had experienced a ‘warning sign’, but only
63/1732 (3.6%) mentioned cancer as a possible cause. Lower education was associated with
lower likelihood of cancer suspicion: 2.6% of respondents with school-only education versus
7.3% with university education suspected cancer as a possible cause. In multivariable analysis,
low education was the only demographic variable independently associated with lower cancer
suspicion (odds ratio (OR) = 0.34, conﬁdence interval (CI): 0.20–0.59).
Conclusion: Levels of cancer suspicion were low overall in this community sample, and even
lower in people from less educated backgrounds. This may hinder early symptomatic presenta-
tion and contribute to inequalities in stage at diagnosis.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the
CC BY license (http://creativecommons.org/licenses/by/4.0/).
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1. Introduction
Studies in which cancer patients report retrospectively
on the process of symptom appraisal indicate that not
recognising a symptom as possibly due to cancer is an
important determinant of delay in presentation [1–3].
Prolonged intervals from symptom onset to
help-seeking may increase the risk of late stage diagnosis
[4]. In Denmark and the United Kingdom (UK), where
cancer survival rates are lower than other western coun-
tries with similar healthcare systems [5], there are ongo-
ing campaigns to encourage public awareness of cancer
‘warning signs’ and prompt help-seeking [6,7].
People from lower socioeconomic status (SES) back-
grounds are more likely to be diagnosed with later-stage
disease for several cancer sites [8]. A number of factors
potentially contribute to inequalities in stage of cancer
diagnosis, but one that has attracted interest in recent
years is how quickly people with symptoms present to
their doctor (the so-called ‘patient interval’) [9]. Factors
such as life stress and competing priorities – which tend
to be higher in lower SES groups – have been considered
as potential deterrents to prompt help-seeking [10],
although as the overall primary care consultation rate is
higher in lower SES groups, this is not a strong candidate
for explaining long patient intervals [11]. An extended
patient interval could also be due to individuals with
lower levels of education being less equippedwith the nec-
essary ‘cancer literacy’ to recognise a cancer warning sign
[10].
Surveys of public awareness of cancer, show that
lower SES groups recall fewer cancer warning signs
when tested with standardised psychometric measures
[12–16]. However, this is ‘knowledge in theory’ and
may not translate into diﬀerential symptom recognition
in daily life. Evidence to date indicates that when people
experience a warning sign in everyday life, very few sus-
pect cancer [17], but there have been no studies examin-
ing SES diﬀerences in cancer suspicion in response to
such a symptom.
In the present study, we combined data from two
primary-care-based symptom surveys that used common
methods of recruitment, and the same symptom assess-
ments, to test the hypothesis that people with less educa-
tion are less likely to suspect cancer when they
experience a cancer ‘warning sign’.
2. Methods
2.1. Study population
Questionnaires were mailed to a total of 9771 men
and women aged P50 years, registered at seven
General Practices across London, the South East and
the North West of England, in surveys conducted in
April 2012 and October 2013. Index of Multiple
Deprivation 2007 (IMD 2007) scores at practice level
were used to ensure a range of deprivation in participat-
ing practices. All patients registered at the participating
practices who were P50 years old, without a registered
cancer diagnosis, and deemed suitable to complete the
questionnaire by the doctor (e.g. did not have a mental
illness, learning disability or terminal illness), were eligi-
ble. Non-responders were sent a reminder after 2 weeks.
The study materials and protocol were approved by
NHS London Bridge Research Ethics Committee
(Reference: 11/LO/1970) and all patients gave informed
consent.
2.2. Measures
2.2.1. Demographics
The two surveys used the same questions on marital
status (categorised for analysis as married/cohabiting
versus not married/cohabiting), current employment
(working versus not working), ethnicity (white versus
non-white ethnic background) and education (university
versus below university). Practices gave information on
age and sex for each individual. Education was used as
the marker of individual-level SES as it is considered
more appropriate in an older sample, many of who are
no longer in the workforce [18].
2.2.2. Symptom experience and cancer attributions
Details of the questionnaire used in the ﬁrst survey
have been published [17]. Both questionnaires included
questions on symptom experience phrased as: “In the last
3 months have you had the following” followed by a list of
symptoms. The symptom list included the 10 symptoms
from the Cancer Awareness Measure (CAM), which
had been based on warning signs from Cancer
Research UK’s website [19,20]. All had yes/no response
options (see Table 2 for a full list of symptoms).
For each symptom that respondents had experienced,
they were asked “What do you think caused it?” in a
free-text response (termed open attribution item).
‘Cancer suspicion’ was deﬁned as any instance where
the respondent indicated that they had considered ‘can-
cer’ as a possible cause. People could give more than one
attribution per symptom, and we coded any mention of
cancer.
2.3. Data analysis
Descriptive statistics were completed for demographic
characteristics, symptom frequency and symptom attri-
butions. Non-responder analyses used chi-square and
t-tests. Responses to the open attribution item were
coded by two independent coders (KW and KeW), and
divided into attribution categories [21]: ‘physical’, largely
medical but excluding cancer (e.g. haemorrhoids for
unexplained bleeding), ‘external/normalising’ (e.g. age
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for change in bladder habits), ‘psychological’ (e.g. stress
for change in bowel habits), or ‘cancer.’ ‘Don’t know’
responses were counted separately, and blank responses
were treated as missing. Cohen’s Kappa was used to
assess the degree of agreement in rating symptom attri-
butions, with coeﬃcients >0.80 considered to represent
good agreement [22]. Inter-rater reliability was high,
ranging from Kappa = 0.80 (95% conﬁdence interval
(CI), 0.74–0.86) for persistent unexplained pain to
Kappa = 0.93 (95% CI, 0.89–0.97) for change in the
appearance of a mole.
Complex samples logistic regression analysis was used
to investigate associations between socio-demographic
characteristics and the likelihood of suspecting cancer.
All 71 cancer attributions were included in the regression
model using a ‘sampling with replacement’ (WR) design,
and each participant’s identiﬁcation number included as
a random eﬀect variable. Analyses were run with and
without controlling for practice as a ﬁxed categorical fac-
tor, but as there were no signiﬁcant diﬀerences between
the models, we report them without including practice.
Data were analysed using the Statistical Package for
the Social Sciences (SPSS) 22.0 [23].
3. Results
3.1. Participants
From 9771 people invited to take part in the survey,
3766 (38.5%) sent back a questionnaire, and 6005
(61.5%) did not reply after one reminder. Ten people
did not complete the symptom questions and were there-
fore excluded from the analyses; resulting in a ﬁnal sam-
ple for analysis of 3756. Demographic characteristics
are presented in Table 1. Non-responder analysis showed
that the probability of not respondingwas greater formen
(37.0%) than women (40.3%) [v2(1) = 10.90, p < .01], and
for 50–59 year olds (33.1%) than 60–69 year olds (44.5%)
or those 70 and over (40.4%) [v2(2) = 100.25, p < .001].
3.2. Symptom experience
Nearly half the respondents (1732: 46.1%) had expe-
rienced at least one symptom from the cancer warning
sign list in the past 3 months. The median number of
symptoms reported was 1, the interquartile range was
1, and the full range was 0–10 (frequencies by warning
sign are shown in Table 2). Persistent cough (16.9%)
was the most common, and unexplained bleeding
(2.9%) the least common.
Only a very small proportion (3.6%; 63/1732) of
those who had experienced a ‘warning sign’ mentioned
cancer as a possible cause. Six people suspected cancer
for two of their symptoms, and one person made three
cancer attributions, resulting in a total of 71 cancer sus-
picions. The distribution of cancer suspicion across
symptoms is shown in Table 2. The highest number of
cancer suspicions was for change in the appearance of
a mole (10.7%). The lowest number was for change in
bladder habits (0.7%).
3.3. Socio-demographic diﬀerences in cancer suspicion
To analyse socio-demographic diﬀerences in cancer
suspicion, we examined the odds of suspecting cancer
for any warning sign. In univariate analyses, lack of uni-
versity education (odds ratio (OR) = 0.33, 0.19–0.55)
was associated with being less likely to suspect cancer
(see Table 3). There were no signiﬁcant associations with
sex, age, marital status, employment or ethnicity.
Multivariate logistic regression analyses conﬁrmed an
independent eﬀect of education (OR: 0.34, 0.20–0.59)
after controlling for other demographic variables. See
Table 3.
Table 1
Demographic characteristics (% (n)).
Total samplea,b
n = 3756
Survey 1
n = 1723
Survey 2
n = 2033
Sex Men 46.3 (1723) 46.2 (789) 46.5 (934)
Women 53.7 (1996) 53.8 (920) 53.5 (1076)
Age (years) 50–59 34.6 (1273) 35.7 (609) 33.7 (664)
60–69 37.3 (1374) 36.5 (622) 37.1 (752)
70 28.0 (1030) 27.8 (474) 28.2 (556)
Education* University 38.7 (1422) 40.8 (686) 36.9 (736)
Below university 61.3 (2250) 59.2 (994) 63.1 (1256)
Employment** Working 42.7 (1587) 45.0 (769) 40.7 (818)
Not working 57.3 (2129) 55.0 (939) 59.3 (1190)
Ethnicity*** White 88.5 (3293) 81.2 (1381) 94.7 (1912)
Non-white 11.5 (428) 18.8 (320) 5.3 (108)
a Survey 1 respondents (London) had higher levels of university education, were more likely to be employed, and more likely to be from non-
white ethnic backgrounds than Survey 2 respondents (London, South East and North West of England).
b Totals may vary due to missing data.
* p < .05.
** p < .01.
*** p < .001.
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4. Discussion
This is the ﬁrst study to examine socioeconomic dif-
ferences in the likelihood of interpreting a ‘warning sign’
as suggestive of cancer. We used data from two waves of
a ‘health’ survey to explore attributions in a large symp-
tomatic sample. Despite the presence of public health
campaigns in the UK, cancer suspicion was very unli-
kely in our respondents; only 3.6% mentioned cancer
as a possible cause in the open text responses.
However, as predicted, a lower level of education was
associated with even lower likelihood of suspecting can-
cer. There were no diﬀerences by sex, age, employment,
or marital status. There was a hint that respondents
from non-white ethnic backgrounds were less likely to
suspect cancer than those from white ethnic back-
grounds, but it did not reach statistical signiﬁcance.
Predictably, ‘classic’ warning signs such as ‘unexplained
lump’ or ‘change in the appearance of a mole’ were most
likely to arouse cancer suspicion; however, even for
those symptoms, the rates of cancer suspicion were little
over 1 in 10. Persistent change in bladder habits and
unexplained weight loss were the least likely to arouse
cancer suspicion.
By combining data from two large health surveys, we
had 1732 respondents reporting at least one ‘warning
sign’ in the previous three months, but among these
respondents the total number of cancer mentions was
71. We may therefore have lacked power to detect smal-
ler socio-demographic eﬀects. For the same reason, we
had too few suspicions of cancer to explore
socio-demographic eﬀects at the individual symptom
level. Previous work has suggested that SES diﬀerences
in later-stage cancer diagnoses – which may be partly
the result of late presentation – are concentrated in cer-
tain cancer sites [8]; suggesting that symptom-speciﬁc
analyses would be useful. SES diﬀerences in late stage
of diagnosis are greatest for cancers such as melanoma
or breast, where patients typically present with easily
noticeable symptoms (change in mole, unexplained
lump) [8]. Nonetheless, even for these generally
well-recognised symptoms, there are ‘knowledge gaps’
by SES [12–16]; consistent with the present ﬁndings of
diﬀerences in cancer suspicion. However, we cannot rule
out ‘denial’ as another explanation for the diﬀerences,
and some people may have suspicions that they chose
not to voice. A recent analysis of attitudes to a cancer
diagnosis showed that lower SES respondents were
more likely to believe that cancer treatment was worse
than cancer itself, and less likely to want to know if they
had cancer [24], which might underpin a reluctance to
acknowledge cancer as a possible cause.
The participants in this study were drawn from a UK
community sample population, but as the focus was on
individual characteristics (e.g. symptom interpretation),
our ﬁndings should be generalizable to other healthcare
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settings. Our study is relevant to other countries with
similar General Practice systems, for example, those
included within the International Benchmarking
Partnership [25]. Response rates are almost always a
limitation in community surveys. Our response rate
was 39% which meant we had no information on the
majority of potential respondents; although this is
slightly higher than for some other community surveys
[11]. In combination with the ﬁnding that men and
younger people were less likely to respond, and previous
evidence that non-responders are more likely to come
from deprived residential areas [17], this limits generalis-
ability. We also cannot estimate any response bias asso-
ciated with symptom experience or interpretation;
heightened attention to symptoms could either encour-
age or discourage questionnaire completion.
There was a signiﬁcant proportion of missing data in
the free-text attributions. This was a drawback, but at
the same time it allowed us to identify people’s sponta-
neous attributions rather than prompting them with
pre-deﬁned categories; in keeping with our aim of inves-
tigating the symptom appraisal process without impos-
ing the researcher’s cancer perspective. Another
limitation was the use of simplistic categorisations for
education and ethnicity. Future work should explore
possible inequalities in likelihood of suspecting cancer
in more heterogeneous samples.
The inherent challenge in the ﬁeld of early diagnosis
comes from the fact that most people experiencing
‘warning signs’ don’t have cancer. The low level of
cancer suspicion by patients in this sample (3.6%) is sim-
ilar to the average positive predictive value of cancer
‘warning signs’ [26,27], and similar to the levels of cancer
suspicion observed by doctors themselves in primary
care [28,29]. Despite this, encouraging more people to
visit their doctors is an ongoing priority in the UK,
supported both through public health campaigns [6],
and general advice provided to the public by the
National Health Service [30]. The logic is that these ini-
tiatives should result in more early stage diagnosis, and
there is already some evidence for down-staging in the
case of lung cancer [31], although conversion rates from
secondary care referrals inevitably go down [32]. This
means that more time is spent investigating people
who don’t have cancer, and more people will experience
a ‘false alarm’ which could undermine their likelihood of
seeking help for a similar symptom in the future [33].
Our ﬁnding that people in general have low cancer sus-
picion when they experience ‘warning signs’, and that
this is even lower in those more likely to be diagnosed
at a later stage is important. People may need to be
encouraged to lower their cancer suspicion ‘threshold’
through earlier diagnosis interventions, both at the pub-
lic health and GP level.
One issue for consideration is the tension between
encouraging people to think seriously about symptoms
that could give an early warning of cancer and creating
fear or hypochondriasis. One possibility is that people
may not need to consider cancer as a cause per se. For
example, recent research with colorectal cancer patients
found that men who associated their symptoms with a
potential illness (not necessarily cancer) were quicker
to seek help than those attributing their symptoms to
benign or self-limiting conditions [34]. Encouraging the
public to seek medical advice for bodily changes that
persist could therefore be a valuable approach.
However, it is known that cancer suspicion is a driver
of help-seeking and our ﬁnding of inequalities in the
likelihood of suspecting cancer when a ‘warning sign’
was experienced shows that a better understanding of
the symptom recognition process could help to reduce
inequalities in cancer survival.
Table 3
Prevalence, and unadjusted and adjusted odds ratios of suspecting cancer for one or more ‘warning sign’ in the past 3 months.
Cancer suspicion
N (%)
OR for suspecting cancer
for any ‘warning sign’
(unadjusted), 95% CI
OR for suspecting cancer
for any ‘warning sign’
(adjusted)*, 95% CI
Education University (n = 563) 41 (7.3)
Below university (n = 841) 22 (2.6) 0.33 (0.19–0.55) 0.34 (0.20–0.59)
Sex Men (n = 618) 27 (4.4)
Women (n = 803) 36 (4.5) 0.90 (0.54–1.48) 0.82 (0.50–1.36)
Age, years 50–59 (n = 474) 21 (4.2)
60–69 (n = 492) 24 (4.7) 1.19 (0.67–2.12) 1.15 (0.63–2.12)
70+ (n = 401) 18 (4.6) 0.96 (0.51–1.82) 0.98 (0.47–2.05)
Employment Working (n = 552) 27 (4.9)
Not working (n = 864) 34 (3.9) 0.87 (0.53–1.44) 1.11 (0.61–2.02)
Ethnicity White (n = 1229) 61 (5.0)
Other (n = 188) 2 (1.1) 0.38 (0.11–1.29) 0.40 (0.11–1.42)
Marital status Married/cohabiting (n = 812) 41 (5.0)
Not married/cohabiting (n = 607) 22 (3.6) 0.67 (0.40–1.12) 0.72 (0.42–1.24)
* Adjusted for all other demographic variables reported in the table. Highlighted ﬁgures are statistically signiﬁcant. OR = odds ratio,
CI = conﬁdence interval.
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